|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06160 BEONE MEDICINES
Nominal 
182.300 +4.700 (+2.646%) Non-current Assets
| 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 1,641,678 | 4.007% | 1,578,423 | 1,324,154 | 845,946 | 587,605 |
| Land & other Lease Assets | 148,184 | 6.371% | 139,309 | 95,207 | 109,960 | 117,431 |
| Intangible Assets | 62,704 | 22.720% | 51,095 | 57,138 | 40,616 | 46,788 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 102,418 | -36.184% | 160,490 | 125,362 | 175,690 | 169,821 |
| 1,954,984 | 1.330% | 1,929,317 | 1,601,861 | 1,172,212 | 921,645 | |
Current Assets
| 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | ||
| Inventories | 608,227 | 22.878% | 494,986 | 416,122 | 282,346 | 242,626 | |
| Trade Receivables | 865,080 | 27.918% | 676,278 | 358,027 | 173,168 | 483,113 | |
| Cash & Bank Balances | 4,547,530 | 73.080% | 2,627,410 | 3,171,800 | 3,869,564 | 4,375,678 | |
| Other Current Assets | 212,752 | 10.280% | 192,919 | 257,465 | 882,000 | 2,512,463 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 6,233,589 | 56.168% | 3,991,593 | 4,203,414 | 5,207,078 | 7,613,880 | ||
Current Liabilities
| 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | |||
| Trade Payables | 479,035 | 18.281% | 404,997 | 315,111 | 294,781 | 262,400 | ||
| S-T Debt & Leases | 77,991 | -91.026% | 869,105 | 710,316 | 353,010 | 449,490 | ||
| Other Current Liabilities | 1,271,804 | 35.184% | 940,797 | 784,686 | 820,737 | 887,665 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 1,828,830 | -17.431% | 2,214,899 | 1,810,113 | 1,468,528 | 1,599,555 | |||
| Net Current Assets | 4,404,759 | 147.919% | 1,776,694 | 2,393,301 | 3,738,550 | 6,014,325 | ||
| Total Assets Less Current Liabilities | 6,359,743 | 71.606% | 3,706,011 | 3,995,162 | 4,910,762 | 6,935,970 | ||
Non-current Liabilities
| 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | ||||
| L-T Debt & Leases | 1,014,853 | 381.518% | 210,761 | 219,869 | 243,665 | 245,154 | |||
| Other Non-current Liabilities | 983,696 | 503.391% | 163,028 | 237,966 | 283,742 | 558,253 | |||
| 1,998,549 | 434.673% | 373,789 | 457,835 | 527,407 | 803,407 | ||||
Capital and Reserves
| 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | |||||
| Share Capital | 144 | 4.348% | 138 | 135 | 135 | 133 | ||||
| Reserves | 4,361,050 | 30.881% | 3,332,084 | 3,537,192 | 4,383,220 | 6,132,430 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 4,361,194 | 30.879% | 3,332,222 | 3,537,327 | 4,383,355 | 6,132,563 | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 4,361,194 | 30.879% | 3,332,222 | 3,537,327 | 4,383,355 | 6,132,563 | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | |
| Commitments | -- | -- | 522,956 | 995,266 | 1,156,236 | 1,002,140 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 06/03/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD 286,933 |
| %Change | -- |
| EPS / (LPS) | USD 0.200 |
| NBV Per Share ($) | USD 2.831 |